Gene · 6876
Papers4,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deeper insights into transcriptional features of cancer-associated fibroblasts: An integrated meta-analysis of single-cell and bulk RNA-sequencing data. | Front Cell Dev Biol | 2022 | 36263012 | PubTator, text mining | PubMed |
| Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture. | Sci Rep | 2022 | 36257968 | PubTator, text mining | PubMed |
| The Single-Cell Revelation of Thermogenic Adipose Tissue. | Mol Cells | 2022 | 36254709 | PubTator, text mining | PubMed |
| Single cell meta-analysis of EndMT and EMT state in COVID-19. | Front Immunol | 2022 | 36248845 | PubTator, text mining | PubMed |
| Smad3 regulates smooth muscle cell fate and mediates adverse remodeling and calcification of the atherosclerotic plaque. | Nat Cardiovasc Res | 2022 | 36246779 | PubTator, text mining | PubMed |
| Differentially expressed genes related to lymph node metastasis in advanced laryngeal squamous cell cancers. | Oncol Lett | 2022 | 36245825 | PubTator, text mining | PubMed |
| Nascent polypeptide-Associated Complex and Signal Recognition Particle have cardiac-specific roles in heart development and remodeling. | PLoS Genet | 2022 | 36240221 | PubTator, text mining | PubMed |
| A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | Int J Mol Sci | 2022 | 36232890 | PubTator, text mining | PubMed |
| WNT1 Inducible Signaling Pathway Protein 1 Is a Stroma-Specific Secreting Protein Inducing a Fibroblast Contraction and Carcinoma Cell Growth in the Human Prostate. | Int J Mol Sci | 2022 | 36232736 | PubTator, text mining | PubMed |
| Profound Effects of Dexamethasone on the Immunological State, Synthesis and Secretion Capacity of Human Testicular Peritubular Cells. | Cells | 2022 | 36231125 | PubTator, text mining | PubMed |
| Endothelial-to-Mesenchymal Transition in Atherosclerosis: Friend or Foe? | Cells | 2022 | 36230908 | PubTator, text mining | PubMed |
| Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics. | Cancers (Basel) | 2022 | 36230803 | PubTator, text mining | PubMed |
| Palmitic acid inhibits vascular smooth muscle cell switch to synthetic phenotype via upregulation of miR-22 expression. | Aging (Albany NY) | 2022 | 36227173 | PubTator, text mining | PubMed |
| Decoding the transcriptome of calcified atherosclerotic plaque at single-cell resolution. | Commun Biol | 2022 | 36224302 | PubTator, text mining | PubMed |
| Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 | 36222710 | PubTator, text mining | PubMed |
| Exosomes: mediators regulating the phenotypic transition of vascular smooth muscle cells in atherosclerosis. | Cell Commun Signal | 2022 | 36221105 | PubTator, text mining | PubMed |
| Upregulation of miR-222-3p alleviates the symptom of aortic dissection through targeting STAT3. | Life Sci | 2022 | 36216078 | PubTator, text mining | PubMed |
| Comparative proteomics reveals elevated CCN2 in NGLY1-deficient cells. | Biochem Biophys Res Commun | 2022 | 36209585 | PubTator, text mining | PubMed |
| High-throughput 3D microvessel-on-a-chip model to study defective angiogenesis in systemic sclerosis. | Sci Rep | 2022 | 36209279 | PubTator, text mining | PubMed |
| Decoding the colorectal cancer ecosystem emphasizes the cooperative role of cancer cells, TAMs and CAFsin tumor progression. | J Transl Med | 2022 | 36209225 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6876/papers?page=47